You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.

On Jun 20, we issued an updated research report on Hill-Rom Holdings, Inc. (HRC - Free Report) . The company is witnessing a solid uptick in domestic revenues, driven by a sturdy performance in Patient Support Systems and Front-Line Care. The stock carries a Zacks Rank #3 (Hold).

Shares of Hill-Rom have outperformed the broader industry in the past year. The stock has rallied 19% compared with the industry's 8.5% rise.



Notably, Hill-Rom exited the first quarter of 2019 on a strong note. Core revenues increased 6%, reflecting a steady progress toward establishing a more durable and diversified business profile. This also marked the fourth consecutive quarter of driving mid-single-digit core revenue growth. Further, the company saw a solid year-over-year increase in domestic revenues on the back of a robust performance by Patient Support Systems and Front Line Care.

The contribution from new products too has been a significant catalyst for top-line growth in the first half of fiscal 2019, accounting for approximately 300 basis points of growth. This is in line with the company’s expectations of generating $400 million in new product revenue growth during fiscal 2019.

We are upbeat about the company’s strong momentum across its diversified product portfolio, which includes Centrella Smart+ bed, Welch AllynConnex Spot Monitor, Monarch Airway Clearance System and Integrated Table Motion for the da Vinci Xi Surgical System. The acquisition of Voalte buoys optimism on the stock as it boosts Hill-Rom’s digital and mobile communications platform.

However, adverse foreign exchange and a fiercely competitive landscape remain headwinds. Also, Hill-Rom’s global revenue rise was sluggish in the reported quarter.

Some better-ranked stocks in the broader medical space are Cerner Corporation (CERN - Free Report) , Penumbra (PEN - Free Report) and Teleflex Inc., (TFX - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market. Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Our experts cut down 220 Zacks Rank #1 Strong Buys to the 7 most likely to jump in price immediately.

On average, the full Strong Buy list has more than doubled the market for 30 years. See its 7 best stocks now.

This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.91% per year. These returns cover a period from January 1, 1988 through May 6, 2019. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.

Api 5l Pipe

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service.

Steel Pipes And Tubes - Steel Pipe Suppliers, Stainless Steel Products | RELIANCE,https://www.rmrsteel.com/